| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10218331 | Critical Reviews in Oncology/Hematology | 2018 | 8 Pages |
Abstract
Good prognosis patients receiving FDT lose their prognostic advantage over high-risk patients receiving CT and high-risk patients may benefit from more intensive maintenance including proteasome inhibitors and immunomodulators.
Related Topics
Health Sciences
Medicine and Dentistry
Hematology
Authors
Mattia D'Agostino, Lorenzo De Paoli, Concetta Conticello, Massimo Offidani, Roberto Ria, Maria Teresa Petrucci, Stefano Spada, Magda Marcatti, Lucio Catalano, Milena Gilestro, Tommasina Guglielmelli, Luca Baldini, Barbara Gamberi, Rita Rizzi,